{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,12]],"date-time":"2026-09-12T09:08:26Z","timestamp":1789204106764,"version":"build-2803163510"},"reference-count":27,"publisher":"MDPI AG","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Am Podiatr Med Assoc"],"published-print":{"date-parts":[[2012,5]]},"abstract":"<jats:sec>\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>Painful diabetic neuropathy remains a difficult pathologic condition to manage effectively despite numerous pharmacologic interventions. A randomized, placebo-controlled, double-blind study was undertaken to determine whether topical 5% ketamine cream is effective in reducing the pain of diabetic neuropathy.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>\n                      Seventeen diabetic patients completed the study. The Michigan Neuropathy Screening Instrument was used to determine whether the neuropathy was likely caused by the diabetic condition. Hemoglobin A\n                      <jats:sub>1c<\/jats:sub>\n                      levels were measured before treatment. Patients applied 1 mL of either ketamine cream or placebo cream for 1 month. The intensity of seven different pain characteristics was evaluated before and after treatment. A two-way repeated analysis of variance design was used to test for differences between treatments and within patients (time).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>We found no significant treatment main effect, but pain improved significantly over time in both groups. There was no statistical interaction effect (treatment \u00d7time) in any of the pain characteristics, indicating that pain improved in the two treatment groups similarly with time.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions:<\/jats:title>\n                    <jats:p>The 5% topical ketamine cream was no more effective than was placebo in relieving pain caused by diabetic neuropathy. (J Am Podiatr Med Assoc 102(3): 178\u2013183, 2012)<\/jats:p>\n                  <\/jats:sec>","DOI":"10.7547\/1020178","type":"journal-article","created":{"date-parts":[[2014,4,1]],"date-time":"2014-04-01T09:44:34Z","timestamp":1396345474000},"page":"178-183","source":"Crossref","is-referenced-by-count":47,"title":["Topical Ketamine Cream in the Treatment of Painful Diabetic Neuropathy"],"prefix":"10.3390","volume":"102","author":[{"given":"James M.","family":"Mahoney","sequence":"first","affiliation":[{"name":"Department of Podiatric Medicine, College of Podiatric Medicine and Surgery, Des Moines University, Des Moines, IA. Dr. Hall is now with the Department of Veteran\u2019s Affairs Southern Arizona, Tucson, AZ. Dr. Peterson is now with Health Partners Institute\/Regions Hospital, St. Paul, MN."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vassilios","family":"Vardaxis","sequence":"additional","affiliation":[{"name":"Human Performance Lab, Des Moines University, Des Moines, IA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joshua L.","family":"Moore","sequence":"additional","affiliation":[{"name":"University Hospital\/University of Medicine and Dentistry of New Jersey, Newark, NJ."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew M.","family":"Hall","sequence":"additional","affiliation":[{"name":"Department of Podiatric Medicine, College of Podiatric Medicine and Surgery, Des Moines University, Des Moines, IA. Dr. Hall is now with the Department of Veteran\u2019s Affairs Southern Arizona, Tucson, AZ. Dr. Peterson is now with Health Partners Institute\/Regions Hospital, St. Paul, MN."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kyle E.","family":"Haffner","sequence":"additional","affiliation":[{"name":"West Houston Medical Center, Houston, TX."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew C.","family":"Peterson","sequence":"additional","affiliation":[{"name":"Department of Podiatric Medicine, College of Podiatric Medicine and Surgery, Des Moines University, Des Moines, IA. Dr. Hall is now with the Department of Veteran\u2019s Affairs Southern Arizona, Tucson, AZ. Dr. Peterson is now with Health Partners Institute\/Regions Hospital, St. Paul, MN."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","reference":[{"key":"b1-1020178","series-title":"Curr Opin Neurol","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1097\/00019052-199410000-00008","article-title":"Pain mechanisms in neuropathy.","volume":"7","author":"Ochoa, JL","year":"1994","unstructured":"Ochoa, JL\n          . :Pain mechanisms in neuropathy. .Curr Opin Neurol7::407. ,1994. .10.1097\/00019052-199410000-000087804461"},{"key":"b2-1020178","series-title":"Pharmacol Rev","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1124\/pr.55.1.1","article-title":"Topical and peripherally acting analgesics.","volume":"55","author":"Sawynok, J","year":"2003","unstructured":"Sawynok, J\n          . :Topical and peripherally acting analgesics. .Pharmacol Rev55::1. ,2003. .1261595110.1124\/pr.55.1.1"},{"key":"b3-1020178","series-title":"Pain","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1016\/S0304-3959(99)00098-6","article-title":"Evidence for an inflammation-induced change in the local glutamatergic regulation of postganglionic sympathetic efferents.","volume":"83","author":"Coggeshall, RE","year":"1999","unstructured":"Coggeshall, RE and SMCarlton. :Evidence for an inflammation-induced change in the local glutamatergic regulation of postganglionic sympathetic efferents. .Pain83::163. ,1999. .1053458710.1016\/S0304-3959(99)00098-6"},{"key":"b4-1020178","series-title":"Neurosci Lett","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/0304-3940(95)11889-5","article-title":"Localization and activation of glutamate receptors in unmyelinated axons of rat glabrous skin.","volume":"197","author":"Carlton, SM","year":"1995","unstructured":"Carlton, SM, GLHargett, and RECoggeshall. :Localization and activation of glutamate receptors in unmyelinated axons of rat glabrous skin. .Neurosci Lett197::25. ,1995. .10.1016\/0304-3940(95)11889-58545047"},{"key":"b5-1020178","series-title":"Eur J Pharmacol","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1016\/0014-2999(95)00449-U","article-title":"Glutamate participates in the peripheral modulation of thermal hyperalgesia in rats.","volume":"284","author":"Jackson, DL","year":"1995","unstructured":"Jackson, DL, CBGraff, JDRichardson, et al. :Glutamate participates in the peripheral modulation of thermal hyperalgesia in rats. .Eur J Pharmacol284::321. ,1995. .10.1016\/0014-2999(95)00449-U8666015"},{"key":"b6-1020178","series-title":"Eur J Pharmacol","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1016\/S0014-2999(97)00072-1","article-title":"Excitatory amino acid receptor involvement in peripheral nociceptive transmission in rats.","volume":"324","author":"Lawland, NB","year":"1997","unstructured":"Lawland, NB, WDWillis, and KNWestlund. :Excitatory amino acid receptor involvement in peripheral nociceptive transmission in rats. .Eur J Pharmacol324::169. ,1997. .10.1016\/S0014-2999(97)00072-1"},{"key":"b7-1020178","series-title":"Anesth Analg","doi-asserted-by":"publisher","first-page":"1730","DOI":"10.1213\/01.ANE.0000086618.28845.9B","article-title":"Ketamine in chronic pain management: an evidence-based review.","volume":"97","author":"Hocking, G","year":"2003","unstructured":"Hocking, G and MCousins. :Ketamine in chronic pain management: an evidence-based review. .Anesth Analg97::1730. ,2003. .1463355110.1213\/01.ANE.0000086618.28845.9B"},{"key":"b8-1020178","series-title":"Pain","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/S0304-3959(97)00006-7","article-title":"Ketamine, an NMDA receptor antagonist, suppresses spatial and temporal properties of burn-induced secondary hyperalgesia in man: a double-blind, cross-over comparison with morphine and placebo.","volume":"72","author":"Warncke, T","year":"1997","unstructured":"Warncke, T, AStubhaug, and EJorum. :Ketamine, an NMDA receptor antagonist, suppresses spatial and temporal properties of burn-induced secondary hyperalgesia in man: a double-blind, cross-over comparison with morphine and placebo. .Pain72::99. ,1997. .10.1016\/S0304-3959(97)00006-79272793"},{"key":"b9-1020178","series-title":"Pain","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1016\/0304-3959(95)00113-1","article-title":"NMDA receptor blockade in chronic neuropathic pain: a comparison of ketamine and magnesium chloride.","volume":"64","author":"Felsby, S","year":"1995","unstructured":"Felsby, S, JNielsen, LArendt-Nielsen, et al. :NMDA receptor blockade in chronic neuropathic pain: a comparison of ketamine and magnesium chloride. .Pain64::283. ,1995. .10.1016\/0304-3959(95)00113-1"},{"key":"b10-1020178","series-title":"Pharmacol Exp Ther","first-page":"1060","article-title":"Prolonged analgesic effect of ketamine, an N-methyl-d-aspartate receptor inhibitor, in patients with chronic pain.","volume":"289","author":"Rabben, T","year":"1999","unstructured":"Rabben, T, PSkjelbred, and IOye. :Prolonged analgesic effect of ketamine, an N-methyl-d-aspartate receptor inhibitor, in patients with chronic pain. .Pharmacol Exp Ther289::1060. ,1999. ."},{"key":"b11-1020178","series-title":"Neurology","doi-asserted-by":"publisher","first-page":"1391","DOI":"10.1212\/01.WNL.0000055848.00032.39","article-title":"Topical ketamine treatment of postherpetic neuralgia.","volume":"60","author":"Quan, D","year":"2003","unstructured":"Quan, D, BSWellish, and DHGilden. :Topical ketamine treatment of postherpetic neuralgia. .Neurology60::1391. ,2003. .10.1212\/01.WNL.0000055848.00032.3912707455"},{"key":"b12-1020178","series-title":"Pain Med","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1046\/j.1526-4637.2000.00006.x","article-title":"Topical ketamine gel: possible role in treating neuropathic pain.","volume":"1","author":"Gammaitoni, A","year":"2000","unstructured":"Gammaitoni, A, RMGallagher, and MWelz-Bosna. :Topical ketamine gel: possible role in treating neuropathic pain. .Pain Med1::97. ,2000. .10.1046\/j.1526-4637.2000.00006.x15101968"},{"key":"b13-1020178","series-title":"J Pain","doi-asserted-by":"publisher","first-page":"644","DOI":"10.1016\/j.jpain.2005.04.008","article-title":"Topical amitriptyline and ketamine in neuropathic pain syndromes: an open-label study.","volume":"6","author":"Lynch, ME","year":"2005","unstructured":"Lynch, ME, AJClark, JSawynok, et al. :Topical amitriptyline and ketamine in neuropathic pain syndromes: an open-label study. .J Pain6::644. ,2005. .10.1016\/j.jpain.2005.04.00816202956"},{"key":"b14-1020178","series-title":"Diab Care","doi-asserted-by":"publisher","first-page":"340","DOI":"10.2337\/diacare.29.02.06.dc05-1549","article-title":"Neuropathy among the diabetes control and complications trial cohort 8 years after trial completion.","volume":"29","author":"Martin, CL","year":"2006","unstructured":"Martin, CL, JAlbers, WHHerman, et al. :Neuropathy among the diabetes control and complications trial cohort 8 years after trial completion. .Diab Care29::340. ,2006. .10.2337\/diacare.29.02.06.dc05-1549"},{"key":"b15-1020178","series-title":"Clin J Pain","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1097\/00002508-198906000-00005","article-title":"The subjective experience of acute pain: an assessment of the utility of 10 indices.","volume":"5","author":"Jensen, MP","year":"1989","unstructured":"Jensen, MP, PKaroly, EFO\u2019Riordan, et al. :The subjective experience of acute pain: an assessment of the utility of 10 indices. .Clin J Pain5::153. ,1989. .10.1097\/00002508-198906000-000052520397"},{"key":"b16-1020178","series-title":"Pain","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/0304-3959(86)90228-9","article-title":"The measurement of clinical pain intensity: a comparison of six methods.","volume":"27","author":"Jensen, MP","year":"1986","unstructured":"Jensen, MP, PKaroly, and SBraver. :The measurement of clinical pain intensity: a comparison of six methods. .Pain27::117. ,1986. .378596210.1016\/0304-3959(86)90228-9"},{"key":"b17-1020178","series-title":"Eur J Clin Pharmacol","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1007\/BF00605995","article-title":"The use of pain scales in assessing the efficacy of analgesics in post-operative dental pain.","volume":"23","author":"Seymour, RA","year":"1982","unstructured":"Seymour, RA\n          . :The use of pain scales in assessing the efficacy of analgesics in post-operative dental pain. .Eur J Clin Pharmacol23::441. ,1982. .10.1007\/BF006059957151849"},{"key":"b18-1020178","series-title":"Eur J Neurol","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1111\/j.1468-1331.2004.00791.x","article-title":"EFNS guidelines on neuropathic pain assessment.","volume":"11","author":"Cruccu, G","year":"2004","unstructured":"Cruccu, G, PAnand, NAttal, et al. :EFNS guidelines on neuropathic pain assessment. .Eur J Neurol11::153. ,2004. .1500916210.1111\/j.1468-1331.2004.00791.x"},{"key":"b19-1020178","series-title":"JAMA","doi-asserted-by":"publisher","first-page":"1602","DOI":"10.1001\/jama.1955.02960340022006","article-title":"The powerful placebo.","volume":"159","author":"Beecher, HK","year":"1955","unstructured":"Beecher, HK\n          . :The powerful placebo. .JAMA159::1602. ,1955. .10.1001\/jama.1955.02960340022006"},{"key":"b20-1020178","series-title":"JAMA","doi-asserted-by":"publisher","first-page":"1609","DOI":"10.1001\/jama.1994.03510440069036","article-title":"The importance of placebo effects in pain treatment and research.","volume":"271","author":"Turner, JA","year":"1994","unstructured":"Turner, JA, RADeyo, JDVon Loeser, et al. :The importance of placebo effects in pain treatment and research. .JAMA271::1609. ,1994. .788022110.1001\/jama.1994.03510440069036"},{"key":"b21-1020178","series-title":"Pain","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1016\/S0304-3959(98)00140-7","article-title":"Size is everything: large amounts of information are needed to overcome random effects in estimating direction and magnitude of treatment effects.","volume":"78","author":"Moore, RA","year":"1998","unstructured":"Moore, RA, DGavaghan, MRTramer, et al. :Size is everything: large amounts of information are needed to overcome random effects in estimating direction and magnitude of treatment effects. .Pain78::209. ,1998. .10.1016\/S0304-3959(98)00140-79870574"},{"key":"b22-1020178","series-title":"Neuroreport","doi-asserted-by":"publisher","first-page":"941","DOI":"10.1097\/00001756-199703030-00025","article-title":"Peripheral NMDA and non-NMDA glutamate receptors contribute to nociceptive behaviors in the rat formalin test.","volume":"8","author":"Davidson, EM","year":"1997","unstructured":"Davidson, EM, RECoggeshall, and SMCarlton. :Peripheral NMDA and non-NMDA glutamate receptors contribute to nociceptive behaviors in the rat formalin test. .Neuroreport8::941. ,1997. .10.1097\/00001756-199703030-000259141069"},{"key":"b23-1020178","series-title":"J Invest Dermatol","doi-asserted-by":"publisher","first-page":"468","DOI":"10.1038\/jid.2008.241","article-title":"Tumorigenic effect of some commonly used moisturizing creams when applied topically to UVB-pretreated high risk mice.","volume":"129","author":"Lu, Y","year":"2009","unstructured":"Lu, Y, YLou, JXie, et al. :Tumorigenic effect of some commonly used moisturizing creams when applied topically to UVB-pretreated high risk mice. .J Invest Dermatol129::468. ,2009. .1870410610.1038\/jid.2008.241"},{"key":"b24-1020178","series-title":"BMJ","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1136\/bmj.39048.407928.BE","article-title":"Comparison of treatment effects between animal experiments and clinical trials: systematic review.","volume":"334","author":"Perel, P","year":"2007","unstructured":"Perel, P, IRoberts, ESena, et al. :Comparison of treatment effects between animal experiments and clinical trials: systematic review. .BMJ334::197. ,2007. .1717556810.1136\/bmj.39048.407928.BE"},{"key":"b25-1020178","series-title":"Anesth Analg","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1213\/01.ANE.0000067406.52093.BF","article-title":"Peripheral antihyperalgesic and analgesic actions of ketamine and amitriptyline in a model of mild thermal injury in the rat.","volume":"97","author":"Oatway, M","year":"2003","unstructured":"Oatway, M, AReid, and JSawynok. :Peripheral antihyperalgesic and analgesic actions of ketamine and amitriptyline in a model of mild thermal injury in the rat. .Anesth Analg97::168. ,2003. .10.1213\/01.ANE.0000067406.52093.BF"},{"key":"b26-1020178","series-title":"Clinical focus: the spectrum of topical agents for the treatment of psoriasis","author":"Becker, E","unstructured":"Becker, E and JKoo. :Clinical focus: the spectrum of topical agents for the treatment of psoriasis .Available at: http:\/\/www.medscape.org\/viewarticle\/588415. .Accessed March 15, 2010."},{"key":"b27-1020178","series-title":"Can Med Assoc J","first-page":"1182","article-title":"Percutaneous absorption.","volume":"110","author":"Brisson, P","year":"1974","unstructured":"Brisson, P\n          . :Percutaneous absorption. .Can Med Assoc J110::1182. ,1974. .4597976"}],"container-title":["Journal of the American Podiatric Medical Association"],"original-title":[],"link":[{"URL":"https:\/\/japmaonline.org\/view\/journals\/apms\/102\/3\/1020178.xml","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/meridian.allenpress.com\/japma\/article-pdf\/102\/3\/178\/1406494\/1020178.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/japmaonline.org\/downloadpdf\/journals\/apms\/102\/3\/1020178.xml","content-type":"text\/html","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/japmaonline.org\/downloadpdf\/journals\/apms\/102\/3\/1020178.xml","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T10:12:14Z","timestamp":1783505534000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1930-8264\/102\/3\/178"}},"subtitle":["A Randomized, Placebo-controlled, Double-blind Initial Study"],"short-title":[],"issued":{"date-parts":[[2012,5]]},"references-count":27,"journal-issue":{"issue":"3"},"URL":"https:\/\/doi.org\/10.7547\/1020178","relation":{},"ISSN":["8750-7315","1930-8264"],"issn-type":[{"value":"8750-7315","type":"print"},{"value":"1930-8264","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,5]]}}}